Navigation » List of Schools » International College of Health Sciences » Nursing » Nursing 1141- Pharmacology » Fall 2022 » Mastery EAQ Ch. 26
Below are the questions for the exam with the choices of answers:
Question #1
A The dose will be decreased.
B The dose will be increased.
C The medication will be stopped.
D The dose will be unchanged.
Question #2
A Is a candidate for fondaparinux based on a sufficient creatinine clearance and adequate body weight
B Not a candidate for fondaparinux based on an insufficient creatinine clearance
C Is a candidate for fondaparinux based on sufficient creatinine clearance and after body weight attains an adequate level
D Not a candidate for fondaparinux based on both an insufficient creatinine clearance and an inadequate body weight
Question #3
A Within normal limits
B Too high
C Inadequate to evaluate treatment
D Too low
Question #4
A Significantly elevated
B Significantly decreased
C Within normal limits
D Inadequate to evaluate treatment
Question #5
A Monitor liver enzymes.
B Administer prescribed vitamin K if bruising is observed.
C Assess for dysrhythmias.
D Stop the medication if the systolic blood pressure drops below 110 mm Hg.
Question #6
A Administering the medication when convenient
B Massaging the site after the injection
C Checking if the patient’s prescription contains enoxaparin
D Administering the medication intramuscularly in the vastus lateralis
Question #7
A “I refrain from drinking coffee and citrus fruit juices daily.”
B “I do not take aspirin for pain relief.”
C “I take ginkgo supplements for memory enhancement.”
D “I eat 1 cup of green leafy vegetables daily.”
Question #8
A “I avoid tight-fitting stockings or leggings.”
B “I’ve been on prolonged bed rest.”
C “I never sit with my legs crossed at the knees.”
D “I get up and walk around at least once an hour.”
Question #9
A Phytonadione
B Aminocaproic acid
C Alteplase
D Tranexamic acid
Question #10
A Cimetidine
B Cholestyramine
C Barbiturate
D Carbamazepine
Question #11
A Heart rate, Hemoglobin, Blood pressure
B Platelet count, Heart rate, Blood pressure
C Hemoglobin, Platelet count, Activated partial thromboplastin time (aPTT)
D Activated partial thromboplastin time (aPTT), Blood pressure, Heart rate
Question #12
A “I will take the medication with food.”
B “I will store the bottle in a dry place.”
C “I will use the medication within 60 days after it is opened.”
D “I will place the pills in an organizer for easy use.”
Question #13
A Loss of 10 pounds
B Creatinine clearance of 25 mL/min
C Diagnosis of diabetes mellitus
D Platelet count of 80,000/mm3
Question #14
A The dosage of the amiodarone will be decreased by half.
B The dosage of the warfarin will be increased by half.
C The dosage of the warfarin will be decreased by half.
D The dosage of the amiodarone will be increased by half.
Question #15
A Monitor the patient for increased action of the anticoagulant.
B Continue to administer cimetidine with each dose of warfarin.
C Instruct the patient to notify the nurse if he or she begins to experience discomfort.
D Monitor the patient for decreased action of the anticoagulant.
Question #16
A Local thrombosis from a peripheral intravenous line
B Peptic ulcer disease
C Severe chest pain for the past 2 hours
D Gastrointestinal bleed
Question #17
A Notify the health care provider immediately.
B Increase the dose of heparin.
C Monitor the patient and check the therapeutic range.
D Stop the medication.
Question #18
A Outside the expected target therapeutic level of anticoagulation; it is too low
B Outside the expected target therapeutic level of anticoagulation; it is too high
C Cannot be interpreted without knowing the prothrombin time and international normalized ratio
D Within the expected target therapeutic level of anticoagulation
Question #19
A Prothrombin time: 13 sec
B Leukocyte count: 3000 cells/mm3
C Platelet count: 100,000/mm3
D Hemoglobin level: 11 g/dL
Question #20
A Peptic ulcer disease, Chronic kidney disease
B History of myocardial infarction, Chronic obstructive pulmonary disease
C Chronic obstructive pulmonary disease, Atrial fibrillation
D Atrial fibrillation, History of myocardial infarction
Question #21
A Platelet count of 95,000/mm3
B Activated partial thromboplastin time (aPTT) of 37 seconds
C Potassium level of 3.5 mEq/L
D International normalized ratio (INR) of 1
Question #22
A Outside the expected target therapeutic level of anticoagulation; it is too high
B Within the expected target therapeutic level of anticoagulation
C The prothrombin time and activated partial thromboplastin time (aPTT) value are needed to interpret the finding.
D Outside the expected target therapeutic level of anticoagulation; it is too low
Question #23
A “Refrigerate and keep away from direct sunlight.”
B “Discard the drug within 21 days of opening the original container.”
C “Remove from the original package and place in aluminum foil.”
D “Store the drug with the desiccant-drying agent in the packing cap.”
Question #24
A Amiodarone
B Ketoconazole
C Furosemide
D Enoxaparin
Question #25
A Teach the patient about dietary restrictions while on the medication.
B Ensure that a loading dose was initially administered when beginning
C Monitor the patient’s laboratory values correctly.
D Have protamine sulfate readily available at all times.
Question #26
A Administer vitamin K1 (phytonadione) IV.
B Stop the intravenous (IV) drip.
C Wait for the INR to decrease.
D Administer protamine sulfate IV.
Question #27
A A quick decrease in pain
B Reversal of damage from the infarction
C Dissolution of the clot that caused the heart attack
D Prevention of new clots from forming
Question #28
A “I should not use any acetaminophen during the therapy.”
B “I should follow a low-cholesterol diet during the therapy.”
C “I should take oral contraceptives during the therapy.”
D “I should refrain from eating broccoli during the therapy.”
Question #29
A “I should keep taking ibuprofen for my arthritis.”
B “I will double my dose if I forget to take it the day before.”
C “I should use a soft toothbrush for dental hygiene.”
D “I should decrease the dose if I start bruising easily.”
Question #30
A “The only difference is that regular heparin dosing is based on the patient’s weight.”
B “You should ask your doctor why dalteparin was ordered instead of regular heparin.”
C “Dalteparin is a low-molecular-weight heparin that is more predictable in its effect and has a lower risk of bleeding.”
D “There is no real difference; dalteparin is interchangeable with regular heparin.”
Question #31
A Draw up the medication in a syringe with a 22-gauge, 1.5-inch needle.
B Administer the medication into subcutaneous tissue of the abdomen.
C Utilize the Z-track method to inject the medication.
D Rub the administration site after injecting.
Question #32
A “I will increase dark green leafy vegetables in my diet.”
B “I will avoid contact sports.”
C “I will take my medication at the same time each day.”
D “I will contact my health care provider if I develop excessive bruising.”
Question #33
A Vitamin K
B Calcium gluconate
C Protamine sulfate
D Vitamin E
Question #34
A Recombinant factors
B Warfarin daily
C Vitamin K daily
D Aspirin daily (i.e., 81 mg)
Question #35
A Peripheral vascular disease
B Transient ischemic attack
C Vitamin K deficiency
D Acute unstable angina
Question #36
A Dabigatran orally
B Heparin subcutaneously
C Warfarin orally
D Enoxaparin intramuscularly
Question #37
A Ingestion of acetaminophen
B Urine culture
C Platelet level
D Over-the-counter medications
Question #38
A October 1
B September 15
C August 29
D July 31
Question #39
A Nausea
B Chest pain
C Itching
D Edema
Question #40
A Blood urea nitrogen (BUN) level of 12 mg/dL
B International normalized ratio (INR) of 1.0
C Activated partial thromboplastin time (aPTT) of 120 seconds
D Platelet count of 150,000 mm3
Question #41
A Fasting blood glucose level of 95 mg/dL
B Creatinine clearance value of 40 mL/min
C Platelet count of 75,000 cell/μL
D Hemoglobin level of 16.5 g/dL
Question #42
A Vitamin K
B Factor Xa
C Antithrombin III
D Thrombin
Question #43
A Desmopressin
B Tranexamic acid
C Aminocaproic acid
D Alteplase
Question #44
A Antifibrinolytic
B Thrombolytic
C Antiplatelet
D Anticoagulant
Question #45
A Cardiomyopathy
B Heart failure
C Coronary artery disease
D Acute myocardial infarction
Question #46
A Aspirin
B Cilostazol
C Pentoxifylline
D Dipyridamole
Question #47
A Enoxaparin
B Dabigatran
C Fondaparinux
D Argatroban
Question #48
A Selective factor Xa inhibitors
B Direct thrombin inhibitors
C Warfarin
D Heparins
Question #49
A Anticoagulants interfere with drug metabolism.
B Anticoagulants prevent clots from forming.
C Anticoagulants alter platelet function.
D Anticoagulants dissolve clots.
Question #50
A Thrombolytic
B Antiplatelet
C Antifibrinolytic
D Anticoagulant
Question #51
A Fatigue from walking with pain
B Embolus to the lungs
C Medication reaction
D Anxiety
Question #52
A Infusing 50 mL of warfarin sodium
B Administering vitamin K1
C Increasing the dose of enoxaparin
D Administering protamine sulfate
Question #53
A Calcium
B Aspirin
C Vitamin K
D Potassium